NHF12-100

Opening Session

Speakers: Val D. Bias, NHF CEO

Technology has made it possible to genotype, or determine genetic mutations, for people with hemophilia A or B. Find out about NHF's genotyping initiative that is set to launch in 2013. Find out where NHF and its chapter network are headed, and how you can be a part of something bigger than yourself.

Audio CDs: 1

Audio CD

$12.00

$12.00

Subtotal

$12.00